In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 28 for your search:
Cancer Type/Condition:  lobular breast carcinoma
Stage/Subtype:  lobular breast carcinoma
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P0334, NCT01501487

2.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 2009-APBI, WIRB #20091193, NCT01185132

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 102-00-301, NCT01204801

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 41 and over
Sponsor: Other
Protocol IDs: 12-001 Single Fraction IORT, NCT01688388

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 201401160, NCT02076074

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 11595, IRUSANAS0092, NCT00921115

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 03909, NCI-2009-01467, NCT01037790

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000675211, P30CA022453, WSU-2010-056, 2010-056, NCT01147016

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-207, H4913s, NCT01185509

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0818, NCI-2011-01102, NCT01245712

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 041001, NCI-2011-01124, P30CA072720, NCT01417286

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00050068, WCI1937-10, NCT01498588

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: I 108907, NCI-2009-01568, P30CA016056, NCT01754519

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 201310007, NCT01757327

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BRE008-12, NCT01758445

17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 201309084, NCT01779050

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: STU 102012-020, NCT01818999

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98113, NCI-2013-00963, P30CA012197, NCT01869764

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLGK974X2101, 2011-000495-33, NCT01351103

21.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000633754, UCD-CCSO001, 200816282-1, CCSO001, NCT00859157

22.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-222, NCT01113905

23.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 48 and over
Sponsor: Other
Protocol IDs: IORT, NCT01189851

24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-13311, NCI-2010-02342, P30CA016059, NCT01293032

25.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 11-003 Mobetron, NCT01295723
1   
New Search